Loading organizations...
Key people at Heliconia Capital.
Heliconia Capital was founded in 2010 by Derek Lau (Chief Executive Officer & Founder).
Heliconia Capital is a Singapore-based investment firm and wholly-owned subsidiary of Temasek Holdings, specializing in providing growth capital to small and medium-sized enterprises (SMEs) across Singapore and Southeast Asia. The firm manages over S$2 billion in assets under management (AUM), actively partnering with its portfolio companies to facilitate their scaling and enhance their global competitiveness. Its investment strategy targets high-growth sectors, including technology, fintech, artificial intelligence, esports, and entertainment, supporting businesses poised for significant expansion within the region and beyond. Among its recognizable portfolio companies are HRnetGroup and XM Studios, operating under the broader umbrella of its parent, Temasek Holdings, which provides strategic backing. Cynthia Chia currently serves as the Chief Executive Officer, overseeing its investment activities. Heliconia Capital was established in 2010.
Key people at Heliconia Capital.
Heliconia Capital was founded in 2010 by Derek Lau (Chief Executive Officer & Founder).
Heliconia Capital has 5 tracked investments across 3 companies. The latest tracked deal is $130.0M Series A in Tessa Therapeutics in June 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2022 | Tessa Therapeutics | $130.0M Series A | Darren Carroll | Brandon Capital Partners, EQT Life Sciences, INKEF Capital, Mission BioCapital, MP Healthcare Venture Management, Polaris Partners, Sanofi Ventures, EDBI, Heritas Capital, Temasek |
| May 19, 2022 | Glife Technologies | $2.9M Series A Extension | Heliconia Capital | Hibiscus Fund, Quest Ventures |
| Nov 16, 2021 | Glife Technologies | $8.1M Series A | Heliconia Capital | Hibiscus Fund, KB Investment |
| Nov 19, 2019 | Lucence Diagnostics | $20.0M Series A | Kelvin LOH | Boon Hwee KOH, LIM Kaling, Sginnovate |
| Dec 20, 2017 | Tessa Therapeutics | $80.0M Other Equity | Temasek | EDBI, Heritas Capital, Karst Peak Capital |
